Monaghan
MonaghanCouldn't load pickup availability
Product Overview
Product Overview
The Monaghan AeroEclipse II Breath Actuated Nebulizer (BAN) produces aerosol in response to the inspiratory flow of the patient. This on-demand patient therapy leads to less medication waste, higher drug delivery efficiency, and safer working environments. By combining the benefits of breath actuation and superior aerosol particle size, AeroEclipse II BAN delivers the most effective respirable dose of the industry.
Delivers a high respirable dosage with the right particle size to go to the therapeutically relevant lung regions. A proprietary one-way valve protects family members and professionals from toxic secondhand aerosols that could contain harmful pathogens.
Accommodates a wide range of patient breathing patterns including changing Inhalation:Exhalation ratios to avoid potential under-dosing as compared to continuously operating nebulizers
Different tidal volumes and frequencies are used by the patients. The drug given helps them control their disease, but if their nebulizer is continuously producing aerosol, up to two-thirds of it can be lost between breaths and active exhalations, potentially leading to uncontrolled disease states or the need for additional therapy. Breath actuation ensures a steady and reliable dose regardless of the rate and volume of their breaths.
To remove:
To Reattach:
